Asset Management One
GEVA

Asset Management One’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Asset Management One’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-27,200
Closed -$2.71M – 1430
2015
Q1 		$2.71M Sell
27,200
-43,875
-62% -$4.65M 0.03% 590
2014
Q4 		$6.62M Buy
71,075
+29,817
+72% +$2.35M 0.09% 304
2014
Q3 		$2.86M Buy
+41,258
New +$2.95M 0.04% 506

Asset Management One's GEVA Position: Q2 2015 in Review

Asset Management One sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 27,200 shares — an estimated $2.71M sold.

Asset Management One first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $6.62M in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Asset Management One reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Asset Management One sold 27,200 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $2.71M.
  • Asset Management One first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Asset Management One's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $6.62M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Asset Management One's 13F filing for Q2 2015, filed 6 Aug 2015.